These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34360986)

  • 1. Analysis and Fine Specificity of the HCMV-Specific Cell-Free and Cell-Associated Antibody-Dependent Cellular Phagocytosis (ADCP) Responses in Lung Transplant Recipients.
    Eberhard S; Vietzen H; Görzer I; Jaksch P; Puchhammer-Stöckl E
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extent of Cytomegalovirus Replication in the Human Host Depends on Variations of the HLA-E/UL40 Axis.
    Vietzen H; Rückert T; Hartenberger S; Honsig C; Jaksch P; Geleff S; Hammer Q; Romagnani C; Segura-Wang M; Puchhammer-Stöckl E
    mBio; 2021 Mar; 12(2):. PubMed ID: 33727352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Cytomegalovirus (HCMV)-Specific Antibody Response and Development of Antibody-Dependent Cellular Cytotoxicity Against HCMV After Lung Transplantation.
    Vietzen H; Görzer I; Honsig C; Jaksch P; Puchhammer-Stöckl E
    J Infect Dis; 2020 Jul; 222(3):417-427. PubMed ID: 32157310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of human cytomegalovirus DNAaemia and specific granzyme B responses in lung transplant recipients.
    Weseslindtner L; Kerschner H; Steinacher D; Kundi M; Jaksch P; Simon B; Hatos-Agyi L; Scheed A; Klepetko W; Puchhammer-Stöckl E
    Clin Exp Immunol; 2013 Sep; 173(3):438-43. PubMed ID: 23607435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclass-specific antibody responses to human cytomegalovirus in lung transplant recipients and their association with constant heavy immunoglobulin G chain polymorphism and virus replication.
    Simon B; Weseslindtner L; Görzer I; Pollak K; Jaksch P; Klepetko W; Puchhammer-Stöckl E
    J Heart Lung Transplant; 2016 Mar; 35(3):370-377. PubMed ID: 26657280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrapulmonary Human Cytomegalovirus Replication in Lung Transplant Recipients Is Associated With a Rise of CCL-18 and CCL-20 Chemokine Levels.
    Weseslindtner L; Görzer I; Roedl K; Küng E; Jaksch P; Klepetko W; Puchhammer-Stöckl E
    Transplantation; 2017 Jan; 101(1):197-203. PubMed ID: 26910332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human cytomegalovirus-specific and UL40-mediated imprint in the natural killer cell repertoire is associated with antibody-mediated rejection in lung transplant recipients.
    Vietzen H; Jaksch P; Puchhammer-Stöckl E
    J Heart Lung Transplant; 2023 Mar; 42(3):305-314. PubMed ID: 36376218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bidirectional transfer of human cytomegalovirus strains in donor and recipient seropositive lung transplant patients.
    Külekci B; Mollik M; Schwarz S; Perkmann-Nagele N; Geleff S; Jaksch P; Hoetzenecker K; Lambers C; Puchhammer-Stöckl E; Goerzer I
    J Med Virol; 2024 Jul; 96(7):e29770. PubMed ID: 38949200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cytomegalovirus infection in lung transplant recipients triggers a CXCL-10 response.
    Weseslindtner L; Nachbagauer R; Kundi M; Jaksch P; Kerschner H; Simon B; Hatos-Agyi L; Scheed A; Aberle JH; Klepetko W; Puchhammer-Stöckl E
    Am J Transplant; 2011 Mar; 11(3):542-52. PubMed ID: 21219583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cytomegalovirus (HCMV)-specific T cell but not neutralizing or IgG binding antibody responses to glycoprotein complexes gB, gHgLgO, and pUL128L correlate with protection against high HCMV viral load reactivation in solid-organ transplant recipients.
    Lilleri D; Zelini P; Fornara C; Zavaglio F; Rampino T; Perez L; Gabanti E; Gerna G
    J Med Virol; 2018 Oct; 90(10):1620-1628. PubMed ID: 29797330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic and local human cytomegalovirus-specific T-cell response in lung transplant recipients.
    Lilleri D; Gerna G; Bruno F; Draghi P; Gabanti E; Fornara C; Meloni F
    New Microbiol; 2013 Jul; 36(3):267-77. PubMed ID: 23912868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cytomegalovirus load in plasma and bronchoalveolar lavage fluid: a longitudinal study of lung transplant recipients.
    Westall GP; Michaelides A; Williams TJ; Snell GI; Kotsimbos TC
    J Infect Dis; 2004 Sep; 190(6):1076-83. PubMed ID: 15319856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchiolitis obliterans syndrome and early human cytomegalovirus DNAaemia dynamics after lung transplantation.
    Westall GP; Michaelides A; Williams TJ; Snell GI; Kotsimbos TC
    Transplantation; 2003 Jun; 75(12):2064-8. PubMed ID: 12829913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lack of cytomegalovirus-specific cellular immune response may contribute to the onset of organ infection and disease in lung transplant recipients.
    Costa C; Saldan A; Sinesi F; Sidoti F; Balloco C; Simeone S; Piceghello A; Mantovani S; Di Nauta A; Solidoro P; Cavallo R
    Int J Immunopathol Pharmacol; 2012; 25(4):1003-9. PubMed ID: 23298490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential kinetics of human cytomegalovirus load and antibody responses in primary infection of the immunocompetent and immunocompromised host.
    Gerna G; Lilleri D; Fornara C; Bruno F; Gabanti E; Cane I; Furione M; Revello MG
    J Gen Virol; 2015 Feb; 96(Pt 2):360-369. PubMed ID: 25316796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-12-Dependent Cytomegalovirus-Specific CD4+ T Cell Proliferation, T-bet Induction, and Effector Multifunction during Primary Infection Are Key Determinants for Early Immune Control.
    Popescu I; Pipeling MR; Mannem H; Shah PD; Orens JB; Connors M; Migueles SA; McDyer JF
    J Immunol; 2016 Jan; 196(2):877-90. PubMed ID: 26663780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent cytomegalovirus-specific memory responses in the lung allograft and blood following primary infection in lung transplant recipients.
    Shlobin OA; West EE; Lechtzin N; Miller SM; Borja M; Orens JB; Dropulic LK; McDyer JF
    J Immunol; 2006 Feb; 176(4):2625-34. PubMed ID: 16456025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the T-cell response to human cytomegalovirus (HCMV) as detected by cytokine flow cytometry and QuantiFERON-CMV assay in HCMV-seropositive kidney transplant recipients.
    Gabanti E; Lilleri D; Scaramuzzi L; Zelini P; Rampino T; Gerna G
    New Microbiol; 2018 Jul; 41(3):195-202. PubMed ID: 30028473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo monitoring of human cytomegalovirus-specific CD8(+) T-Cell responses using the QuantiFERON-CMV assay in allogeneic hematopoietic stem cell transplant recipients attending an Irish hospital.
    Fleming T; Dunne J; Crowley B
    J Med Virol; 2010 Mar; 82(3):433-40. PubMed ID: 20087937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of multiple cytomegalovirus strains in blood and lung of lung transplant recipients.
    Puchhammer-Stöckl E; Görzer I; Zoufaly A; Jaksch P; Bauer CC; Klepetko W; Popow-Kraupp T
    Transplantation; 2006 Jan; 81(2):187-94. PubMed ID: 16436961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.